Metabolic-Fit / 100
Vaylen review
A rare compounded-plus-brand shop with five real price points disclosed up front — $179/mo compounded semaglutide up to $1,086/mo brand Zepbound — though the oral tablet's exact molecule split isn't fully clear, and there's no postpartum or PCOS-specific content.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Vaylen at a glance
- Semaglutide
- $179/mo compounded
- Tirzepatide
- $239/mo compounded
- Coverage
- Nationwide
- Brand-name
- Yes
How we scored Vaylen
Each factor is scored from Vaylen's real pricing, disclosures and oversight, then combined into the 49/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Limited public detail on who oversees care and how.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.joinvaylen.com
Sourced from WLR's provider directory, independently re-verified live on joinvaylen.com (2026-08-02). All five price points confirmed directly on the homepage. The oral tablet tier's exact molecule split wasn't fully clear from the page copy alone. The displayed semaglutide/tirzepatide fields carry the compounded (lower) price only — brand pricing is documented in the structured pricing rows — to avoid this site's parser reading the much smaller compounded figure against the much larger brand one as ambiguous.
What to expect when you sign up
We walked Vaylen's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The homepage lists five real price points directly — compounded semaglutide, compounded tirzepatide, a compounded oral tablet, plus brand Ozempic and Zepbound — no intake required to see a number
- 2HIPAA-secure intake described as 'clinician-directed' GLP-1 care
- 3Site states clear, transparent pricing with no insurance required and no hidden costs
What we noticed
- One of the more complete public pricing pages in this batch — both compounded and brand options for both molecules are itemized without starting an intake
- The oral tablet tier ('$259/mo') isn't clearly split by molecule on the pricing page — treated conservatively as a semaglutide row here
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $179 | Injectable, starting priceListed as 'Starting At $179/Month.' |
| Oral semaglutide | $259 | Daily dissolvable tabletListed as 'From $259/Month' — one oral tier covers both molecules on the pricing page; treated here as the semaglutide oral option. |
| Brand semaglutide | $997 | Ozempic®Listed as 'Around $997/Month.' |
| Compounded tirzepatide | $239 | Injectable, starting priceListed as 'Starting At $239/Month.' |
| Brand tirzepatide | $1086 | Zepbound®Listed as 'Around $1,086/Month.' |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Vaylen's public disclosures at last review and change often; confirm the current number on Vaylen's own site.
What we like
- Five real price points itemized directly on the homepage — compounded and brand, both molecules — no intake required
- Genuinely offers FDA-approved brand Ozempic and Zepbound alongside compounded options, not just one or the other
- States clear, transparent pricing with no insurance required and no hidden costs
- Compounded oral (needle-free) tablet option available
The caveats
- The oral tablet tier isn't clearly split by molecule on the pricing page
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
- No named compounding pharmacy or medical director found on the site
- Brand pricing ($997-$1,086/mo) is a significant jump from the compounded tiers — confirm which you're selecting before checkout
Vaylen for mothers: our verdict
A rare compounded-plus-brand shop with five real price points disclosed up front — $179/mo compounded semaglutide up to $1,086/mo brand Zepbound — though the oral tablet's exact molecule split isn't fully clear, and there's no postpartum or PCOS-specific content. It runs about $179/month, flat across every dose.
We weigh Vaylen the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a generic weight-loss review skips.
What Vaylen actually costs
- Compounded semaglutide — Injectable, starting price: $179/mo
- Oral semaglutide — Daily dissolvable tablet: $259/mo
- Brand-name semaglutide — Ozempic®: $997/mo
- Compounded tirzepatide — Injectable, starting price: $239/mo
- Brand-name tirzepatide — Zepbound®: $1086/mo
That lands within a few dollars of the ~$177/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
The medications Vaylen prescribes
Vaylen prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own pregnancy and lactation labeling, which is cleaner to hand to an OB.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where Vaylen fits — and where it doesn't — for mothers
A good fit if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Vaylen is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who want to compare compounded and brand pricing side by side on one platform before deciding.
Alternatives to Vaylen
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Vaylen
Head-to-head & alternatives
Vaylen, answered
- How much does Vaylen cost?
- As last verified, Vaylen's compounded pricing starts around $179/month ($179/mo compounded semaglutide, $239/mo compounded tirzepatide). Confirm the current, all-in price on Vaylen's own site before you commit.
- Is Vaylen safe to use while breastfeeding?
- No GLP-1 — compounded or brand — is established as safe during pregnancy or breastfeeding, and the labels advise against use; Vaylen is no exception. Plan any GLP-1 for after weaning, and discuss the timing with your own clinician.
- Does Vaylen offer both semaglutide and tirzepatide?
- Yes — Vaylen offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Vaylen rank for mothers?
- Vaylen scores 49/100 on our Metabolic-Fit Score (rank #37), which weights six factors that matter for mothers. Our #1 pick, CoreAge Rx, leads the ranking — see how they compare.
Pricing, states and verification reflect Vaylen's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.